Olefsky JM - Search Results

1

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM. He W, et al. Among authors: olefsky jm. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15712-7. doi: 10.1073/pnas.2536828100. Epub 2003 Dec 5. Proc Natl Acad Sci U S A. 2003. PMID: 14660788 Free PMC article.

2

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

Barak Y, Liao D, He W, Ong ES, Nelson MC, Olefsky JM, Boland R, Evans RM. Barak Y, et al. Among authors: olefsky jm. Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):303-8. doi: 10.1073/pnas.012610299. Epub 2001 Dec 26. Proc Natl Acad Sci U S A. 2002. PMID: 11756685 Free PMC article.

3

Female rats do not exhibit free fatty acid-induced insulin resistance.

Hevener A, Reichart D, Janez A, Olefsky J. Hevener A, et al. Diabetes. 2002 Jun;51(6):1907-12. doi: 10.2337/diabetes.51.6.1907. Diabetes. 2002. PMID: 12031980

4

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM. Yu JG, et al. Among authors: olefsky jm. Diabetes. 2002 Oct;51(10):2968-74. doi: 10.2337/diabetes.51.10.2968. Diabetes. 2002. PMID: 12351435 Clinical Trial.

5

Beta -Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Galpha s signaling in 3T3-L1 adipocytes.

Hupfeld CJ, Dalle S, Olefsky JM. Hupfeld CJ, et al. Among authors: olefsky jm. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):161-6. doi: 10.1073/pnas.0235674100. Epub 2002 Dec 30. Proc Natl Acad Sci U S A. 2003. PMID: 12509508 Free PMC article.

6

Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding.

Miles PD, Barak Y, Evans RM, Olefsky JM. Miles PD, et al. Among authors: olefsky jm. Am J Physiol Endocrinol Metab. 2003 Mar;284(3):E618-26. doi: 10.1152/ajpendo.00312.2002. Am J Physiol Endocrinol Metab. 2003. PMID: 12556354 Free article.

7

Chronic endothelin-1 treatment leads to insulin resistance in vivo.

Wilkes JJ, Hevener A, Olefsky J. Wilkes JJ, et al. Diabetes. 2003 Aug;52(8):1904-9. doi: 10.2337/diabetes.52.8.1904. Diabetes. 2003. PMID: 12882904

8

Muscle-specific Pparg deletion causes insulin resistance.

Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Hevener AL, et al. Nat Med. 2003 Dec;9(12):1491-7. doi: 10.1038/nm956. Epub 2003 Nov 16. Nat Med. 2003. PMID: 14625542

9

PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.

Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M. Koo SH, et al. Nat Med. 2004 May;10(5):530-4. doi: 10.1038/nm1044. Epub 2004 Apr 25. Nat Med. 2004. PMID: 15107844

10

Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats.

Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM. Satoh H, et al. Among authors: olefsky jm. J Clin Invest. 2004 Jul;114(2):224-31. doi: 10.1172/JCI20785. J Clin Invest. 2004. PMID: 15254589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters